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Abstract 
In this study we explored the psychosocial experiences of melanoma survivors at high risk of 
developing new primary disease. Twenty survivors (9 men, 11 women, mean age 57.6 years) 
completed a semistructured telephone interview, exploring melanoma-related beliefs and 
experiences, psychological adjustment to melanoma risk, and supportive care needs. Participants 
perceived melanoma as potentially terminal and reported persistent worries about the possibility 
of developing new or metastatic disease. Fear of developing a new melanoma endured for years 
after treatment completion and, for some, created a pervasive sense of uncertainty. Still, not a 
single participant sought formal emotional support to address their melanoma-related concerns. 
Belief in the benefits of early intervention, including self- and clinical skin examination, 
provided a sense of control and a recommended course of action in an otherwise uncontrollable 
situation. The expertise of the High Risk Clinic physicians was perceived as instrumental in 
creating a sense of reassurance.  
 
Keywords: cancer, psychosocial aspects; cancer, screening and prevention; coping and 
adaptation; interviews, semistructured; risk, perceptions.  
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Prognosis for patients with localized primary melanoma is good, especially when detected early, 
with 5-year survival rates estimated at 98%. However, individuals who have had melanoma live 
with an increased risk of developing new primary disease. Melanoma survivors are 
approximately eight times more likely to develop a second primary melanoma than the general 
population is of developing a first melanoma (Bradford, Freedman, Goldstein, & Tucker, 2010). 
In Australia, the estimated 10-year risk for the development of a second primary melanoma is 
approximately 13%, and for patients with two melanomas, the risk of developing a third is 28% 
(Doubrovsky & Menzies, 2003). Therefore, for patients who live in regions such as Australia, 
where there is heavy sun exposure and increasing survival rates as a result of early medical 
intervention, the risk of developing subsequent primary melanomas is possibly much greater than 
the risk of a thin lesion developing into metastatic disease (Doubrovsky & Menzies, 2003). 
Furthermore, it is estimated that the risk of developing new primaries remains elevated for more 
than 20 years post original diagnosis (Bradford, et al., 2010). 
In addition to a personal history of melanoma, the presence of multiple atypical moles (or 
dysplastic nevus syndrome, DNS) is a known risk factor for the development of primary 
melanoma (Halpern et al., 1991; Kelly et al., 1995). Past research has shown that the presence of 
dysplastic nevi as a risk factor for developing melanoma has an odds ratio of 2.5 to 8.8 (Halpern, 
et al., 1991). Holly et al. (1987) reported a relationship between the number of dysplastic nevi 
and the subsequent development of melanoma, with a relative risk of 3.8 for participants with 
one to five dysplastic nevi and 6.3 for participants with six or more dysplastic nevi. This 
relationship was confirmed in a more recently published meta-analysis (Gandini et al., 2005). 
Given these established risk factors, a significant proportion of melanoma patients are considered 
to be at high risk of developing new primary disease. Very little is known, however, about the 
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subjective experiences and risk perceptions of individuals at high risk of developing another 
melanoma. The need to assess subjective, risk-related concerns and fears in this group is justified 
given their known high-risk status and ensuing vulnerability to increased melanoma-related 
distress.   
Fear of cancer recurrence (FCR) is the fear that one might develop cancer again, either in 
the same place or another part of the body (Vickberg, 2003). FCR has been explored in a range 
of different cancer groups, including survivors of breast, ovarian, colorectal, prostate, lung, and 
head and neck cancer (Baker, Denniston, Smith, & West, 2005; Hodges & Humphris, 2009; 
Mehta, Lubeck, Pasta, & Litwin, 2003; Northouse, Schafer, Tipton, & Metivier, 1999; Stanton, 
Danoff-Burg, & Huggins, 2002; Stewart, Duff, Wong, Melancon, & Cheung, 2001). Overall, 
between 24% and 40% of cancer survivors report a moderate to high need for greater support in 
coping with FCR (Armes et al., 2009; Katharine Hodgkinson et al., 2007; K. Hodgkinson et al., 
2007; Sanson-Fisher et al., 2000). FCR has been associated with hyper-vigilant health checking 
behaviors (Lasry & Margolese, 1992), poor planning for the future, and decreased psychological 
well-being (Northouse, 1981). Longitudinal cohort studies also indicate that FCR is a relatively 
stable variable, which might not necessarily diminish over time (Deimling, 2002; Mast, 1998; 
Stanton, et al., 2002). 
FCR has not yet been investigated among individuals affected by melanoma, though it 
might be an important area of enquiry given this group’s elevated risk of developing new 
disease. The experience of FCR might also be unique in this population compared to other cancer 
survivors because melanoma survivors typically have multiple scars from the removal of 
suspicious moles and melanomas (Kneier, 2003; Missiha, Solish, & From, 2003; Sollner, Zingg-
Schir, Rumpold, Mairinger, & Fritsch, 1998). This scarring, as well as a skin phenotype that 
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identifies these individuals as above-average risk (including the presence of moles or fair skin), 
might serve as an ever-present cue for risk-related thoughts. The risks associated with sun 
exposure for people with fair skin are well known in western countries with frequent sunshine; 
however, the impact of this psychologically is still largely unknown. There remains a dearth of 
evidence specifically focused on these issues for individuals at high risk of developing 
melanoma and it has not yet been determined whether these cues increase a melanoma survivor’s 
vulnerability to developing FCR.    
Though FCR specifically has not yet been investigated in this context, distress, anxiety, 
and depression have been assessed among individuals affected by melanoma in numerous 
studies. Overall, approximately 30% of patients with melanoma report clinical levels of 
psychological distress (for review, please see (Kasparian, McLoone, & Butow, 2009; Kasparian, 
McLoone, & Meiser, 2009). Melanoma patients report similar levels of distress compared to 
individuals affected by breast or colon cancer, but on average, report higher levels of distress 
when compared to patients with gynecological or prostate cancer (Zabora, Brintzenhofeszoc, 
Curbow, Hooker, & Piantadosi, 2001). Anxiety is also quite prevalent among melanoma 
survivors. A recent review of the literature found that about a quarter of melanoma patients 
(ranging from 18% to 44% across studies) fell within the clinical range on survey-based 
measures of anxiety (Brandberg, Bolund, Sigurdardottir, Sjoden, & Sullivan, 1992; Brandberg, 
Kock, Oskar, af Trampe, & Seregard, 2000; Trask et al., 2001). 
Furthermore, approximately one fifth of patients newly diagnosed with non-metastatic 
melanoma experience depression (Gibertini, Reintgen, & Baile, 1992) and overall, studies have 
found that  6% to 28% of melanoma patients report clinically-relevant levels of depression 
(Bergenmar, Nilsson, Hansson, & Brandberg, 2004; Brandberg et al., 1992; Brandberg, 
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Bergenmar, Michelson, Mansson-Brahme, & Sjoden, 1996; Kelly, et al., 1995). Though 
extensive research has examined psychological adjustment among melanoma survivors in 
general, the subjective experiences and psychological adjustment of melanoma survivors at high 
risk of new disease have not been clearly delineated. 
 Though an individual’s risk of developing melanoma can be calculated in medical terms, 
subjective evaluations of one’s risk might be more complex to assess. Subjective evaluations of 
risk might be determined by a range of different factors and might also influence an individual’s 
psychological adjustment, coping responses, and health behaviors. The Transactional Model of 
Stress and Coping provides a theoretical framework which might be useful in thinking about and 
exploring individual experiences of health threat, and the ways in which people understand and 
act in relation to medical risk (Lazarus & Folkman, 1984). According to this model, stressful 
experiences are construed as person-environment transactions, and these transactions depend on 
the perceived impact of the stressor. When faced with a potential stressor (e.g. the threat of 
developing another melanoma), a person is likely to evaluate the potential threat (primary 
appraisal) and form a judgment about the personal significance of the event. Subsequent to the 
primary appraisal, a secondary appraisal follows; this involves the assessment of one’s coping 
resources and options. Efforts to regulate the stressor, one’s perception of the stressor, or the 
resources available, are part of the coping process and, if effective, will result in increased 
emotional well-being and health-oriented behaviors.  
Guided by the Transactional Model, one would predict that the likelihood of experiencing 
psychological stress is greater if a person is at higher risk of developing melanoma and if he or 
she perceives the threat as severe. The theory would also predict that an individual who did not 
think they had adequate resources at their disposal to manage the threat of developing melanoma 
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would experience greater stress (Folkman & Greer, 2000). When considering adherence to 
melanoma-related health behaviors such as sun protection and skin examination in light of this 
model, an individual is considered more likely to engage in these behaviors if he or she perceives 
him- or herself to be at risk of developing melanoma, if he or she believes them self or their 
physician are capable of performing recommended actions, and if so, that these actions will be 
effective in reducing melanoma risk. However, application of this model within the context of 
high melanoma risk has not been investigated. 
Thus, the purpose of this investigation was three-fold. First, to explore the subjective 
experiences, risk perceptions, and coping responses of melanoma survivors known to be at high 
risk of developing new disease. Second, to evaluate perceptions of emotional and practical 
support received and needed by individuals at high risk of developing another melanoma. And 
third, to consider the findings of the study in light of the Transactional Model of Stress and 
Coping.  
Methods 
In this study we adopted a qualitative data collection strategy, because this method is best suited 
to the exploration of relatively new areas of inquiry (Denzin & Lincoln, 2000).  
Participants 
We recruited study participants using the clinical database of the High Risk Clinic (HRC) at the 
Sydney Melanoma Diagnostic Centre, located within a major teaching hospital, the Royal Prince 
Alfred Hospital, Sydney, Australia. To ensure the heterogeneity of the sample and the 
comprehensiveness of experiences reported, a purposive sampling methodology was used 
(Patton, 2002). In accordance with this approach similar numbers of men and women, as well as 
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individuals from a range of different age groups and with differing clinical features, were 
recruited.  
The clinical criteria used for admission to the HRC was also used for this study. “High-
risk” was defined in both instances as having either multiple diagnoses of primary invasive 
melanoma or the diagnosis of one primary invasive melanoma and the presence of DNS. In 
addition, so that participants had sufficient familiarity with the HRC to be able to comment on it, 
participants were required to have attended a minimum of at least three clinical skin 
examinations (CSE) at the HRC.  Sufficient English language skills to complete the 
semistructured interview without the aid of an interpreter and being of adult age (18 years or 
older) were additional criteria. 
Individuals with a strong family history of melanoma, defined as three or more first- or 
second-degree relatives diagnosed with melanoma or found to carry a p16 mutation, were 
excluded from the study on the grounds that substantial work investigating the psychosocial and 
behavioral experiences of this group has previously been undertaken by our research team 
(Kasparian, Butow, Meiser, & Mann, 2008; Kasparian et al., 2010; Kasparian, Meiser, Butow, 
Job, & Mann, 2007; Kasparian, Meiser, Butow, Job, & Mann, 2006; Kasparian, Meiser, Butow, 
Simpson, & Mann, 2008; Kasparian, Meiser, Butow, Simpson, & Mann, 2009). Exclusion 
criteria also stipulated that individuals receiving active treatment for locally advanced or 
metastatic melanoma were not included, so as not to burden those who were unwell. 
Procedure 
Potential participants were sent a letter of invitation from the Director of the HRC. Those who 
opted into the study took part in a semistructured telephone interview. A guide was used to 
conduct each interview and was developed on the basis of a thorough review of theoretical 
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models in health psychology, including the Transactional Model of Stress and Coping, as well as 
previous research in this area conducted by the research team. Results from early interviews 
were used to suggest additional lines of questioning in subsequent interviews and sampling was 
discontinued once informational saturation was achieved; that is, interview data were collected 
until no new information or themes were disclosed during interviews (Marshall, 1996; Morse, 
1995). The semistructured interview was designed to explore participants’ beliefs about 
melanoma, personal experiences of the disease, psychological adjustment and coping, 
perceptions of one's risk of developing another melanoma, adherence to health behavior 
recommendations, including skin surveillance and sun protection, and perceptions of clinical 
care and support as received at the HRC. In Table 1 we present a summarized version of the 
semistructured interview guide. All interviews were conducted by the same interviewer, lasted an 
average of 47 minutes (range 23-63 minutes), and were audio-taped and transcribed verbatim. 
The interviewer collected demographic data immediately following the interview using a 
verbally-administered questionnaire. Clinical data were obtained from the HRC database. Data 
were collected as part of a larger qualitative study; however, only responses directly relating to 
participants' psychosocial experiences and support needs are reported here. Approval was 
obtained from the relevant Human Research Ethics Committees and informed consent was 
obtained for all participants prior to participation.  
[INSERT TABLE 1 ABOUT HERE.]  
Data Analysis 
We employed the conceptual framework of Miles and Huberman (1994) to guide data analysis. 
Conventional content analysis was used, with coding categories derived directly from transcribed 
text (Hsieh & Shannon, 2005) and organized using the qualitative data analysis software, QSR 
NVivo 8.0 (QSR International, 2008). To establish a reliable system of coding, three members of 
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the research team collaboratively coded four, randomly selected interviews (20%). Each 
transcript was reviewed line-by-line for concepts, themes and ideas from which the preliminary 
coding scheme was constructed. Preconceived codes and categories were not used; rather these 
were derived inductively from the data (Kondracki, Wellman, & Amundson, 2002; Mayring, 
2000). The codes were sorted into hierarchical categories to form organized and meaningful 
clusters. This facilitated the development of a clear structure, or coding tree (Coffey & Atkinson, 
1996; Morse & Field, 1995; Patton, 2002). The thematic coding model was then reviewed by 
experienced analysts within the research team before the remainder of transcripts was 
independently coded by two coders. At the completion of coding, random passages of each 
transcript were re-coded by the alternate coder, who was blind to the original coding. Any 
discrepancies in coding were discussed with the team until a consensus was reached. This 
multilevel consensus coding method has been applied in multiple settings (Hruschka et al., 2004; 
Sankar, Wolpe, Jones, & Cho, 2006) and meets criteria for methodological rigor in qualitative 
research (Denzin & Lincoln, 2000). Emergent themes were cross-tabulated by sample 
characteristics including sex, age, and clinical characteristics, using the query function of QSR 
NVivo 8.0. During analysis, counts were used to minimize researcher bias (Morgan, 1993) and 
participant responses which differed from the general consensus were considered carefully for 
the additional insights offered.  
Results 
Of the twenty-two individuals approached, twenty participants (9 men, 11 women) completed the 
semistructured interview. The mean age of the sample was 57.6 years (SD=11.8; range 34-74 
years). Eight participants (40%) had completed a university degree, 17 participants (85%) were 
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married, and 13 (65%) reported that they and their parents had been born in Australia. The 
clinical characteristics of participants are shown in Table 2.  
[INSERT TABLE 2 ABOUT HERE.]  
In this study we explored the subjective experiences, risk perceptions, coping responses, 
and support needs of individuals at high risk of developing another melanoma. The study 
findings are presented below according to themes, and a concise summary of the results is 
displayed in Table 3. 
[INSERT TABLE 3 ABOUT HERE.]  
Perceptions of Melanoma Risk and Personal Susceptibility 
For the majority of participants, melanoma was perceived as a potentially terminal disease, and 
presented a significant risk to life; “If I'm really lucky it won't be what kills me, but it might be.” 
Participants consistently reported that risk-related worries or concerns persisted over many years. 
For several participants, the possibility of developing new primary disease was a constant 
concern.  
Each time I get another one I have a real sense of “Oh God, here we go again” and I 
wonder if this is going to be the one that gets me. It's not really a burden but it's kind of 
like a shadow I guess and progressively it gets a little bit darker each time. . . . It's going 
to be this constant I guess worry or concern in my life.  
 
Many participants described a chronic sense of fear or anxiety with regards to melanoma, 
and this fear had “no sort of peak to it” but remained “constantly on my mind”. For these 
participants, the risk of developing new primary disease remained an ominous threat, like “a 
sword hanging over my head . . . it's scary.” This fear of melanoma recurrence or the 
development of new disease did not diminish over time, but was experienced over many years, 
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with clinical consultations serving to keep melanoma at the forefront of individuals’ minds. 
“Whenever I go back to [Doctor], he says, `Well it is 7 years, but don't forget it could reoccur at 
any time.' . . . and I suppose all the time I wonder when it's going to happen.”  Throughout this 
time, participants reported living with a pervasive sense of uncertainty regarding if or when 
melanoma would manifest again. “I keep my eye on my glands in my legs and under my arms . . 
. all the time I wonder when it's going to happen.”  
 
Ongoing Fear about the Possibility of Metastases 
Some participants reported feeling “terrified” of the risk of developing metastatic melanoma and 
believed that “if melanoma gets loose in your body, you've had it.” Most participants believed 
that current treatment options were insufficient to cure metastatic melanoma and if metastasis 
occurred, the chances of survival were perceived as low.  
I don't want to [get melanoma again], it terrifies me. Because I know that there's a lot of 
treatment now, but still, bottom-line is if it's already spread and it's not got really soon, 
really quickly, there's no treatment for it. They can't fix it.  
 
For the majority of participants, the belief that current treatments are ineffective for advanced 
melanoma underscored a strong desire to receive up-to-date information on the latest clinical 
research findings. Indeed, research was perceived as a potential source of hope and reassurance. 
“I know I’ve got a problem, I know I’ve got a danger. It would be nice to get something to 
outline what's happening in the research; what they're doing, the improvements in treatment, 
etc.”  
Beliefs about the Causes of Melanoma and How These Relate to Personal Risk 
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Sun exposure was perceived as a primary cause of melanoma by the majority of participants and 
therefore, being “caught out” in the sun was a source of anxiety for many. “I have active melanin 
and the sun is acting like a switch.”A small proportion of participants reported behaviors 
indicating significant fear about the potential danger of sun exposure, even in a very limited 
quantity. For example, one woman experienced such fear of sun exposure that when outside she 
described hiding in the shadows, “When I’m standing at an intersection I sort of find the shadow 
of a post” believing that even the smallest amount of sun exposure could trigger another 
melanoma.  
For some, these fears interfered with daily life, including the location and timing of 
family activities and pleasurable outdoor events. “It changes holidays. That for me was difficult 
because I loved those holidays where I jumped in the pool. You know, those lovely sort of 
tropical holidays. That's out of the question for me now.” The majority of participants, however, 
reported a more balanced attitude toward UV exposure and an ability to integrate sun protection 
practices and lifestyle choices. “I lead a very outdoor life. We kayak, we backpack, we walk, we 
cross country ski, everything outdoors and I don't intend to shut myself away. So, we take the 
best precautions that we think will work.”  
For most participants, the relationship between sun exposure and melanoma was 
perceived as a simple cause and effect relationship. For some survivors, however, this causal 
relationship was perceived as complex and confusing. Many believed that the sun-worshipping 
culture of their younger years was the primary cause of their melanoma and that “the damage 
was done when I was younger.” Some expressed regret that they had not learned about sun 
protection earlier, for “in your twenties . . . perhaps you could have done more to turn it around.” 
The sense that this had created a “ticking time bomb” for melanoma risk was a compelling fear 
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for these individuals. Yet, this did not seem to be associated with fatalism and many participants 
reported vigilance when it came to the uptake of recommended sun protection practices. Most 
participants were highly motivated to protect themselves and their family members from the sun, 
believing that even the smallest amount of additional sun exposure could trigger their ”dormant” 
melanoma. Confusion was often expressed if melanoma presentation was incongruent with one’s 
pattern of sun exposure, for example, if a melanoma developed after years of living in a cold 
climate or on a part of the body never exposed to the sun. “[The melanoma was] in a place that 
you would not be able to find. I mean no sunlight gets there. I can tell you, I'm not a nudist.” 
Melanoma was, for some, inexplicable and unpredictable in its presentation, and these 
perceptions were associated with uncertainty and anxiety. “I mean my question was why did it 
happen then, when I had been out of the Australian climate for 6 years?”  
Furthermore, in addition to personal fears, several participants also spontaneously 
reported worries concerning their children's or grandchildren's risk of developing melanoma and 
almost half of the sample reported strongly encouraging younger family members to use 
adequate sun protection and have regular skin examinations.  
I know with our grandchildren that what isn't covered by the new modern swim suit, my 
daughter makes sure there's cream everywhere. I think through my experience it's really 
brought all my family to really look [for melanoma]. I've got three children and all their 
children go to check-ups regularly.  
 
Skills and Resources Used To Try To Cope with Melanoma Risk 
The majority of participants' fears about melanoma occurrence or recurrence seemed to be 
attenuated, at least to some extent, by positive beliefs about the benefits of early intervention. 
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Participants gave numerous specific examples of positive beliefs that facilitated healthy 
emotional adjustment to their high-risk status. One such example was the belief that if detected 
early, melanoma could be successfully treated and cause minimal life disruption; “I know it's not 
severe at all if you have it removed quickly.”  Some participants even reported a sense of feeling 
“lucky” that their cancer was outwardly visible, aiding early detection and intervention. “It's 
probably one [cancer] that's a blessing in that if you do get it, it's going to leave a paper trail 
there, or a skin trail, that you've actually got it.”  
Regular skin self-examination (SSE) and CSE were another form of active coping 
reported by this group. For many, SSE and CSE provided a sense of control and a recommended 
course of action in an otherwise uncontrollable situation. Vigilant self-screening behavior was 
reported by many participants as a means of alleviating anxieties about melanoma. “I do it every 
time I think of it. Yeah it could be weekly. It's very scary. By checking I feel much more 
comfortable after I've done it.” For some participants, however, self-screening did not provide 
the same emotional benefits. Indeed, a subset of participants expressed a reluctance to rely on 
their own ability to detect changes in the appearance of lesions or moles through SSE. Rather, 
these individuals expressed a clear preference for relying on the highly trained HRC clinicians to 
examine their skin for changes suggestive of cancer. “I want to pay somebody who has studied 
this problem for years and who can diagnose it at the drop of a hat. I don't want to be relying on 
myself. I wouldn't be confident at all.” Indeed, the expertise of the doctors at the HRC was 
perceived by almost all participants as instrumental in creating a sense of safety and reassurance 
in the context of their melanoma risk status. “I get a lot of comfort from the experience and the 
reputation of the Sydney Melanoma Unit to deal with those sort of things, and . . . if you go 
there, you're getting the experts.”  Many participants reported increased confidence and 
  16 
decreased anxiety after CSEs which found no new disease. As such, adherence to recommended 
CSE regimens was reported by the majority of participants.  
Through the combined approach of routine CSE at the HRC, regular self-screening, and 
healthy sun protection practices, most participants remained positive regarding their future 
health, despite their high risk status.  
I think it would be very unlikely and unlucky if one was missed. I mean, as unlucky as 
just being hit by a bus. I actually don't feel fearful. Because I have a fantastic team that 
look after me and I check myself and I'm now really careful, I'm always covered.  
 
However, the need for life-long sun protection and skin screening practices affected individuals 
differently. Those who could integrate recommended health behaviors into their health regime 
and “just get on with life” adjusted well; “I just pretty much kept on going with my life as per 
normal. Except, I . . . obviously avoided the sun - excessively, not completely.” For some 
though, the implementation of melanoma-related health behaviors was seen as a considerable 
impingement on their lifestyle; “For me it is a complete hassle because I’ve got so many 
bloomin’ moles on me. . . . I have got to live with this skin for the rest of my life, be always 
monitoring it.” For those whose life choices were more substantially impacted by their 
melanoma risk, coping with living at high risk of developing new disease was experienced as 
more difficult.  
[The doctor] said, “Look, we will never tell you not to have any more children but it's 
extremely obvious from your case study that . . . it's because of pregnancy”. . . . I want to 
have a third child, but if I'm going to have another melanoma or another problem, I don't 
think I will do it. I think, ‘Oh my God I might die!’ and my baby won’t even know me 
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and she will be brought up by somebody else. . . . I remember I would sit on the lounge 
and cry of a night to my husband going, ‘What if I die?  What will happen to her?’ 
 
Self-concept and Perceptions of Physical Disfigurement after Melanoma Treatment  
Several participants who had had multiple melanomas and suspicious lesions removed described 
their experience of treatment as being, “like death by a thousand cuts”.  However, even these 
participants appeared to cope relatively well with the ensuing scarring, reporting limited distress 
or loss of self-esteem or self-confidence; “Oh, they're just a part of me now.” Indeed, all but one 
participant demonstrated healthy adjustment to the appearance of scars resulting from incisions 
made during treatment; “Oh look, I couldn't care less about scarring. I would rather a scar than, 
you know, be dead.” Some even found a positive side to having either a melanoma or a lymph 
node removed.  
Hey, I'm alive, who cares. One of the boys down at the beach thought a shark had got me. 
. . . Where they've cut away there it just gives me a little bit more length between the 
hand and the armpit. It's the only side I can tuck the [surf]board under comfortably. 
 
Views on Supportive Care and Areas of Unmet Need  
Few participants identified themselves as a “cancer survivor”, which in turn limited their sense 
of legitimacy in seeking emotional or practical support.  
I don't think I've had any [support] . . . I don't even go to things like the cancer afternoon 
teas. . . . I guess in a weird kind of way I don't think of myself as a cancer survivor . . .  
because it's not the same as, you know, breast cancer or liver cancer . . . so I would feel 
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like a bit of a fraud there I guess. And perhaps that’s why I haven’t felt the need to go and 
seek counseling or anything like that. 
 
Although friends were cited as a source of support, they seemed to offer little empathy for the 
patient’s cancer-related concerns. This might have been because of a lack of awareness of the 
risks inherent with a diagnosis of malignant melanoma.  
There're just so many people that don't understand how dangerous [melanomas] are. Like 
I've had many people say, “Oh you've just had a mole removed” and I'm like, “It's 
actually cancer believe it or not”. So yeah there's a wrong perception from most people. 
The actual depth of what one is I think is missed.  
 
Not a single participant had, at any time, sought formal emotional support or counseling to 
address their melanoma-related worries or concerns. For many participants, the thought of 
accessing such support had not even been considered as an option; however, in hindsight, several 
participants believed that newly diagnosed patients could greatly benefit from professional 
support. They believed consultation with a psychologist, trained to understand and address the 
unique and specific needs and concerns of individuals diagnosed with melanoma, would be 
valuable.  
Discussion 
Melanoma risk perceptions and anxiety 
Participants at high risk of developing new primary melanoma reported experiencing melanoma-
related anxiety, a finding consistent with past research (Kasparian, McLoone, & Butow, 2009), 
and the theoretical constructs of the Transactional Model of Stress and Coping (TMSC). By 
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examining these issues qualitatively, the present study provides a more nuanced understanding of 
high-risk melanoma patients’ concerns and appraisals of disease risk and threat. Participants 
reported persistent worries associated with thoughts of melanoma recurrence, metastases and the 
risk of their children/grandchildren developing melanoma sometime in the future. Many reported 
a pervasive sense of uncertainty and some participants struggled at times to cope with not 
knowing “if” or “when” they would develop melanoma again. Participants believed that their 
personal risk of developing what they considered a life-threatening disease, remained high for 
years after treatment completion. In terms of the TMSC, participants’ primary appraisal of 
melanoma was, in the majority of cases, that the disease represented an uncertain, but potentially 
severe and terrifying threat. This sense of uncertainty is a common phenomenon often described 
by cancer patients and survivors, and is recognized in Mishel’s model of Uncertainty in Illness 
(1988). Uncertainty in illness has been associated with increased psychological distress, 
decreased quality of life, and difficulty coping (Wright, Afari, and Zautra, 2009). Feelings of 
uncertainty are likely to fluctuate across time, making it essential to measure this construct 
longitudinally in order to better understand the relationship between uncertainty and  adjustment 
to chronic or potentially recurrent illnesses, such as melanoma.  
Psychological Adjustment and Risk Reduction Behaviors 
As predicted by the TMSC, concerns regarding the development of new disease often prompted 
sun protection behaviors, including the use of sunscreen and limiting time spent in the sun. 
Participants who believed that sun exposure was a cause of melanoma, but also that there were 
viable ways to manage this risk factor, tended to report greater  psychological adjustment. These 
findings support the TMSC which purports that during the secondary appraisal process an 
individual will assess what they can do about a specific stressful situation. Those who perceive 
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the available resources as sufficient to minimize the risk, tend to report greater emotional well-
being and more proactive health behaviors.  
Participants who perceived even low levels of UV exposure as dangerous were more 
likely to consider sun protection recommendations as burdensome and disruptive because of the 
high level of care required to protect oneself. The inability to successfully integrate sun 
protection behaviors within daily life was often reported as distressing and might have created a 
sense of cognitive dissonance; the unpleasant internal state that arises when individuals notice 
inconsistencies between their attitudes and their behaviors (Baron & Byrne, 1997; Festinger, 
1962). This finding is consistent with the idea, derived from the TMSC, that negative secondary 
appraisals (i.e. a person’s perceived inability to reduce the threat of the presenting stressor), are 
associated with greater psychological stress. As such, the development of an effective 
intervention or resource, which includes helpful suggestions regarding the integration of sun 
protection recommendations into a healthy and balanced lifestyle, might be beneficial for this 
high-risk group.   
Perceptions of Risk, Reassurance and the High Risk Clinic   
Patients attending the HRC viewed their clinicians as experts and as such, felt that it would be 
“as unlucky as just being hit by a bus” for new disease to remain undetected while in their care. 
The HRC, with its biannual skin screening protocol, provided much-needed reassurance for those 
living at high-risk of developing new disease. Participants reported that they felt safe because 
they were being monitored and cared for by experts on a regular basis. Fear of cancer recurrence 
was commonly reported among participants and the risk associated with failing to notice an 
important change in one’s skin provoked considerable anxiety in some. As such, participants 
who reported low self-efficacy with regards to SSE also reported a preference for the “experts” 
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at the HRC to conduct all skin examinations. According to this subset of participants, the HRC 
provided the resources they deemed necessary to allay the threat of melanoma. Thus, stress 
responses were lowered and coping behaviors (i.e. CSE attendance) were increased.  
Though it is important that the HRC was able to provide reassurance for these patients, 
their singular reliance on CSE might not be considered ideal. Self-efficacy, a person’s belief in 
his or her ability to accomplish a given task or goal, appears important for survivors’ to adopt 
SSE practice. Personal control and self-efficacy have been shown to explain a considerable 
proportion of variance in the adoption of health behaviors (Godin & Kok, 1996; Klein & 
Stefanek, 2007; Schwarzer & Fuchs, 2001), and a sense of control is often related to reductions 
in fatalistic beliefs and existential uncertainty (Lipworth, Davey, Carter, Hooker, & Hu, 2010). It 
might therefore be helpful for clinicians to discuss patient’s attitudes toward SSE, their sense of 
self-efficacy, and how this may be affected by the complexity of their phenotype (for example, 
among individuals with DNS), within psycho-educational consultations.  
Implications for the Clinical Care of Patients at High-Risk of New Primary Melanoma 
Clinicians are regularly faced with the task of conveying risk-related information to patients. It is 
important for clinicians to relay this information clearly and to appreciate that a person’s 
understanding of risk-related messages is often based on a number of factors additional to the 
medical information provided. A patient’s personality, level of comprehension, and experience 
of stress while receiving risk information, are just a few of the factors which might impact the 
patient’s beliefs and understanding of their level of risk as communicated by their doctor (Haines 
et al., 2010). Given that risk-related beliefs influence health behaviors (Klein & Stefanek, 2007), 
any doctor-patient misunderstandings might have important long-term consequences for patient 
health and well-being. It is therefore important for clinicians to verify their patients’ 
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understanding of risk, so that inaccurate risk-related beliefs might be checked and anxieties 
addressed in a sensitive and caring manner. Effectively tailoring doctor-patient communication 
of risk to patient characteristics is essential within the clinical setting.  
Clinical practice guidelines for the management of melanoma consistently recommend 
that structured psychosocial interventions and psycho-education be made available to all 
melanoma patients (Australian Cancer Network, 2008). Based on the results presented herein, it 
is apparent that a large discrepancy exists between the level of medical support and reassurance 
HRC patients receive, and the level of psychological, emotional and social support received. 
While the majority of participants reported healthy adjustment to their melanoma risk and 
described active coping responses, it is concerning that a substantial proportion also reported 
concurrent and persistent uncertainty, anxiety and fears regarding recurrence. Not a single 
participant in the current study reported seeking or receiving professional emotional support, 
despite a desire for such support from some individuals. It appears that this reticence may stem, 
in part, from patients’ perception that because melanoma is a visible cancer, and therefore 
detectable at an early, curable stage, the term ‘cancer survivor’ does not apply to them. Greater 
support in this area, therefore, appears warranted for melanoma survivors at high-risk of 
developing new primary disease. When making mental health referrals, it is important to discuss 
psychosocial needs with patients in a way that normalizes or supports help-seeking behavior, so 
as to limit any stigma or concerns that might hinder seeking or receiving help. Openness around 
this issue, on the part of the clinician, is especially important given that some patients might 
believe asking for further help could be considered ungrateful or a negative reflection of the 
medical care they are currently receiving, and as such, remain reticent to express a need for 
greater support. 
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Table 1. Sample Questions from the Semistructured Interview Schedule 
Topic of Discussion Sample Questions 
Thoughts and beliefs about melanoma What are the first two things that come to mind when you think about melanoma? 
Beliefs about how melanoma is caused What do you believe causes melanoma? 
The  experience of having melanoma Can you try to describe how you felt around the time of diagnosis / treatment / follow 
up care? 
Beliefs about risk How would you describe your chances of developing another melanoma sometime in 
the future compared to others? 
Sun protection and skin surveillance 
behaviors 
What types of things do you do, if any, to try to reduce your chances of developing 
another melanoma? 
Beliefs about moles and melanoma How do you feel about any moles or related scars, that you currently have on your 
body? 
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Table 2. Clinical Characteristics of the Sample 
Clinical Variables Mean (SD) 
Time (years) since:   
     First diagnosis 11.7 (8.9) 
     Most recent diagnosis 6.2 (6.0) 
Number of melanomas per person  2.4 (1.4) 
Average Breslow thickness (mm)  1.0 (1.0) 
Personal history of melanoma  n (%) 
     One  melanoma  7 (35%) 
     Multiple  melanomas 13 (65%) 
Dysplastic naevus syndrome       n (%) 
     Yes  14 (70%) 
     No 6 (30%) 
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Table 3. A Conceptual Summary of the Major Themes Contributing to 
Participants’ Perceptions of Melanoma Risk and Clinical Care 
Major Themes Participant Quotations as Evidence 
Fear It terrifies me. . .  in the back of my mind there’s still the risk that there could be 
something there. 
Persistent uncertainty I just feel like it’s a sword hanging over my head. I guess because you are always 
keeping an eye on things, it’s always there – it’s like an undercurrent in your life. 
If I'm really lucky [melanoma] won't be what kills me, but it might be. 
Threat perceived as pervasive  Even though it’s 15 degrees [the sun] can still burn you. . .  you can get caught out. 
Causal attributions We always got sun burnt, so that’s obviously why I’m paying for it now. 
Controllability  I know it’s not severe at all if you have it removed quickly. 
Behavioral responses to threat I don’t go in the sun, I don’t take any risks. 
I check myself and I'm now really careful. 
Low confidence in one’s ability to detect 
melanoma (i.e. self-efficacy)   
I don’t trust that I will pick up on any changes [indicative of developing melanoma]. 
Specialized medical care I knew I was getting the best care available.  Probably in the world. 
Barriers to accessing emotional support I don’t think of myself as a cancer survivor. . .  because it’s not the same as, you 
know, breast cancer or liver cancer. . .  so I would feel like a bit of a fraud there I 
guess. And perhaps that’s why I haven’t felt the need to go and seek counselling or 
anything like that. 
Feeling (mis)understood There’s just so many people that don’t understand how dangerous [melanoma] are. 
 
 
 
 
